miR-150-5p at the Interface of Cancer Biology and Immune Regulation: Dual Roles, Mechanisms, and Therapeutic Opportunities
Iris Lin, Pardis Shirkani, Cathie Garnis · 2026
Read miR-150-5p at the Interface of Cancer Biology and Immune Regulation: Dual Roles, Mechanisms, and Therapeutic Opportunities by Iris Lin, Pardis Shirkani, Cathie Garnis (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13280537.txt.
Description
Iris Lin and colleagues published a 2026 review of miR-150-5p, a regulatory RNA with a double life in cancer and immunity. MicroRNAs fine-tune gene activity, and this one can suppress tumors in some settings yet promote them in others. The outcome depends on cancer type and surroundings. The review covers blood cancers and solid tumors, tracing how the molecule influences cell growth, death, and spread.
Special attention goes to copies packaged into extracellular vesicles, the parcels cells use to message each other. Through them it reshapes the tumor neighborhood, blood vessel growth, and immune escape. The authors detail its governance of macrophages, dendritic cells, T cells, and natural killer cells, central to anti-tumor defense. Therapeutic ideas run into delivery problems and off-target risks, which the review weighs. Their bottom line: miR-150-5p has value as a biomarker and as a drug target, provided context is respected.
Catalog record
| CREATOR | Iris Lin, Pardis Shirkani, Cathie Garnis |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |